4.64 USD
↘ 0.08 (1.69%)AT CLOSE (03:59 PM EST)
Savara Inc.
SVRANASDAQ • USD
4.69
↗ 0.05 (0.97%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
4.69
↗ 0.05 (0.97%)
Market: CLOSED
Savara Inc. (SVRA) trades at $4.64 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, SVRA is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 13, 2026.
Open?$4.80
High?$4.85
Low?$4.58
Prev. Close?$4.72
Volume?3.2M
Avg. Volume?2.7M
VWAP?$4.71
Rel. Volume?1.18x
Bid / Ask
Bid?$4.66 × 100
Ask?$4.71 × 3.0K
Spread?$0.05
Midpoint?$4.69
Valuation & Ratios
Market Cap?1.0B
Shares Out?205.5M
Float?143.3M
Float %?69.8%
P/E Ratio?N/A
P/B Ratio?9.49
EPS?-$0.69
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Employees
70
Market Cap
1.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1996-11-18
Address
6836 BEE CAVE ROAD
AUSTIN, TX 78746
Phone: 51285113796
AUSTIN, TX 78746
Phone: 51285113796
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?90
Momentum?23
Short Sent.?34
Piotroski F-Score?0/9Weak
Altman Z-Score?3.88Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?22.52%Squeeze Risk
Short Interest?32.3M
Days to Cover?12.9
Free Float143.3M
Avg Daily Volume2.5M
Settlement Date2026-10-30
Financial Health
Current Ratio?8.55Strong
Quick Ratio?8.55Strong
Cash Ratio?1.79Strong
Debt/Equity?0.28Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?9.49HIGH▾
Peers100
S&P20
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-6.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-141.6%WEAK▾
S&P3
ROA?-98.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-130945000
Enterprise Value?$1.0B
Fundamentals ratios updated end of day